Review  

Triple-negative breast cancer

Reinaldo D Chacón, María V Costanzo Breast Cancer Research 2010, 12(Suppl 2):S3 (22 October 2010)

Abstract | Full text | PDF

Research article  

Identification of biology-based breast cancer types with distinct predictive and prognostic features: role of steroid hormone and HER2 receptor expression in patients treated with neoadjuvant anthracycline/taxane-based chemotherapy

Silvia Darb-Esfahani, Sibylle Loibl, Berit M Müller, Marc Roller, Carsten Denkert, Martina Komor, Karsten Schlüns, Jens Uwe Blohmer, Jan Budczies, Bernd Gerber, Aurelia Noske, Andreas du Bois, Wilko Weichert, Christian Jackisch, Manfred Dietel, Klaus Richter, Manfred Kaufmann, Gunter von Minckwitz Breast Cancer Research 2009, 11:R69 (16 September 2009)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

Review  

Recent advances in systemic therapy. When HER2 is not the target: advances in the treatment of HER2-negative metastatic breast cancer

David W Miles Breast Cancer Research 2009, 11:208 (28 August 2009)

This article is part of a collection on Recent advances in...

Abstract | Full text | PDF | PubMed

Research  

Does vimentin help to delineate the so-called 'basal type breast cancer'?

Renata U Kusinska, Radzislaw Kordek, Elzbieta Pluciennik, Andrzej K Bednarek, Janusz H Piekarski, Piotr Potemski Journal of Experimental & Clinical Cancer Research 2009, 28:118 (20 August 2009)

Abstract | Full text | PDF | PubMed